SCHEMBL19636070

SCHEMBL19636070

c1ccc2c(c1)ccc1c3cc4c(cc3[nH]c21)sc1ccc2ccccc2c14

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.51
ALDH1A1 P00352 4/20 0.38
HPGD P15428 4/20 0.38
KDM4E B2RXH2 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
CDK4 P11802 3/20 0.37
CCND1 P24385 3/20 0.37
CCNB2 O95067 1/20 0.37
CCNE2 O96020 1/20 0.37
PRKCG P05129 1/20 0.37
PRKCB P05771 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
PRKCA P17252 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
GSK3B P49841 1/20 0.37
MAP3K9 P80192 1/20 0.37
MAP3K11 Q16584 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19636277 0.94 KIF11 (0.51) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19636224 0.87 KIF11 (0.56) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL17573754 0.86 AHR (0.49) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19831790 0.84 CDK4 (0.44) KIF11ALDH1A1HPGDKDM4ECDK4
SCHEMBL18665863 0.84 KIF11 (0.49) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19831792 0.82 KIF11 (0.53) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19832057 0.82 CDK4 (0.51) KIF11ALDH1A1KDM4ECDK4CCND1
SCHEMBL19831910 0.81 KIF11 (0.56) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19636279 0.80 AHR (0.41) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19831908 0.80 AHR (0.53) KIF11ALDH1A1HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713291-B2 Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-08-01 US disclosed
WO-2020085793-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2020-04-30 WO disclosed
US-20190185411-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-06-20 US disclosed
US-20190131543-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-05-02 US disclosed
WO-2017200320-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 덕산네오룩스 주식회사 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185411-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF PIEZO1, ORAI2, EXOC1 KIF11 2727/4885ALDH1A1 2268/4885HPGD 3668/4885
US-11713291-B2 Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof PIEZO1, ORAI2, EXOC1 KIF11 2727/4885ALDH1A1 2268/4885HPGD 3668/4885
US-20190131543-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, PIEZO1, ORAI2 KIF11 3641/4885ALDH1A1 2829/4885HPGD 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.